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Background: MicroRNAs (miRNAs) are a class of small RNA molecules that regulate expression of specific mRNA
targets. They can be released from cells, often encapsulated within extracellular vesicles (EVs), and therefore have
the potential to mediate intercellular communication. It has been suggested that certain miRNAs may be selectively
exported, although the mechanism has yet to be identified. Manipulation of the miRNA content of EVs will be
important for future therapeutic applications. We therefore wished to assess which endogenous miRNAs are
enriched in EVs and how effectively an overexpressed miRNA would be exported.
Results: Small RNA libraries from HEK293T cells and vesicles before or after transfection with a vector for
miR-146a overexpression were analysed by deep sequencing. A subset of miRNAs was found to be enriched in EVs;
pathway analysis of their predicted target genes suggests a potential role in regulation of endocytosis. RT-qPCR in
additional cell types and analysis of publicly available data revealed that many of these miRNAs tend to be widely
preferentially exported. Whilst overexpressed miR-146a was highly enriched both in transfected cells and their EVs,
the cellular:EV ratios of endogenous miRNAs were not grossly altered. MiR-451 was consistently the most highly
exported miRNA in many different cell types. Intriguingly, Argonaute2 (Ago2) is required for miR-451 maturation
and knock out of Ago2 has been shown to decrease expression of other preferentially exported miRNAs (eg miR-
150 and miR-142-3p).
Conclusion: The global expression data provided by deep sequencing confirms that specific miRNAs are enriched
in EVs released by HEK293T cells. Observation of similar patterns in a range of cell types suggests that a common
mechanism for selective miRNA export may exist.
Keywords: microRNA, Deep sequencing, Extracellular vesicles, ExosomesBackground
Membrane-bound extracellular vesicles (EVs), are referred
to by various terms in the literature, including microvesi-
cles or microparticles. However, they may be divided into
two main types formed either by budding of the plasma
membrane (shedding vesicles, ectosomes; approximately
100 nm −1 μm in diameter) or by exocytosis of multivesi-
cular bodies (MVB) (exosomes; approximately 50–
100 nm) [1-3]. While it is important to recognize that
these two main populations of EVs have distinct biogen-
esis pathways, it remains technically challenging to isolate* Correspondence: David.Simpson@qub.ac.uk
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Northern Ireland, UK
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distribution, and reproduction in any mediumtheir respective pure populations due to their overlapping
size distributions and most preparations are therefore het-
erogeneous [3]. EVs are targeted to specific recipient cells
by surface receptors which mediate their internalisation
and uptake of their content, comprising lipids, proteins,
mRNAs and microRNAs (miRNAs) [2,4]. A significant
physiological role for EVs is supported by their implication
in cancer progression, angiogenesis, cell reprogramming
and differentiation [5-9].
MiRNAs are a class of small RNA molecules that
regulate gene expression by binding to specific mRNA
targets and triggering their degradation or inhibiting
their translation. Primary miRNAs (pri-miRNAs), tran-
scribed either as independent genes or as introns of cod-
ing genes, are processed to form precursor hairpin loopsCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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III enzymes Drosha and Dicer respectively. One strand
of the mature miRNA is loaded into an RNA induced si-
lencing complex (RISC), which mediates the interaction
between the miRNA and its target mRNA molecules.
Argonaute (Ago) proteins are part of the RISC and me-
diate cleavage of target mRNAs [10,11].
Recently, miRNAs have been found extracellularly,
being encapsulated within vesicles (EVs), or associated
with Ago2 or NPM1 proteins or high-density lipoproteins
(HDL) [12-19]. EV preparations isolated by ultracentrifu-
gation are heterogeneous and include both exosomes and
other vesicles. Extracellular miRNAs have emerged as
prognostic markers for various diseases, such as cancer
and cardiovascular disorders [13,20-23]. Recent studies
have demonstrated that miRNAs can be shuttled between
cells in EVs and modulate gene expression [6,24-26] and
control different physiological functions in the recipients
[27-30].
It has been shown that miRNA export into exosomes
occurs via the ceramide-dependent secretory pathwayFigure 1 Characterization of EVs and their RNA content. A) Transmissio
total and small RNAs of the HEK293T cells and EVs. (Lower peaks for the traand independently of the endosomal sorting complex
required for transport (ESCRT) [24]. Although the
mechanism of release of shedding vesicles is less well
known, the role of P4-ATPase and ESCRT has been
recognized recently [31]. Several studies have suggested
that the miRNA content of EVs does not simply reflect
the miRNA repertoire of the cells of origin and that
some miRNAs are selectively exported or retained
within the cell [25,27,32-34]. However, the mechanism
whereby specific miRNAs are selectively exported is
unknown.
The potential for exploiting extracellular vesicles as
vehicles for delivery of therapeutic molecules has been
appreciated [35-38]. For example, EVs prepared from a
patient’s own cells could potentially be enriched with
specific siRNAs and/or miRNAs and used as a tool for
therapeutic delivery of these regulatory RNA molecules.
Alternatively, the therapeutic effect could be achieved by
transplanting cells engineered to over-express critical
miRNAs, which are delivered to the target cells via EVs
[33,36]. To most effectively harness EVs as therapeuticn electron microscopy of isolated EVs. B) Bioanalyzer profiles of the
nsfected cells and EVs (blue) are due to less RNA loaded).
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they are loaded with regulatory RNAs.
As a step towards understanding the mechanism of se-
lective export of miRNAs to EVs we have applied deep
sequencing to characterize the global expression pattern
of small RNAs in HEK293T cells and the EVs that they
release. Although the enrichment of overexpressed
miRNA in EVs has been shown by RT-qPCR in
HEK293T cells, mesenchymal stem cells, macrophages
and immune cells [24,25,27,28,37], it is not known to
what extent overexpressed miRNAs are exported intoFigure 2 Over-expression of miR-146a. A) Deep sequencing reads mapp
of miR-146a expressed exogenously following transfection with pSM30-146
reads as for endogenous miR-146a. B) RT-qPCR quantification of miR-146aEVs and how they affect the export of endogenous miR-
NAs. To address these questions, small RNAs from cells
transfected with miR-146a expressing plasmid and their
EVs were also subjected to deep sequencing. Ectopic
overexpression of miR-146a in HEK293T exosomes was
previously shown to exert a functional effect upon re-
cipient cells, including downregulation of target gene ex-
pression [24].
Comparison of our data with other publicly available
data sets of miRNA expression in cells and their EVs
revealed a subset of miRNAs that tend to beed to the miR-146a pre-miR sequence. The most frequent isomiR (red)
a (transfected cells and EVs) is represented by a similar percentage of
in non-transfected and pSM30-146a transfected HEK293T cells.
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common function in intercellular communication.
Results
EVs from HEK293T cells were obtained by ultracentifu-
gation of conditioned media at 100000 g. The presence
of spherical membrane bound structures of variable
diameter up to approximately 1000 nm in these prepara-
tions was confirmed by transmission electron micros-
copy (Figure 1A). RNA extracted from cells and EVs was
analyzed on a Bioanalyzer (Agilent Technologies). The
shape of the RNA profiles observed when comparing
RNA from pSM30-miR-146a transfected cells and EVs
and their non-transfected counterparts were similar
(Figure 1B). Total RNA from EVs was enriched in small
RNAs and lacked ribosomal RNA peaks typical for cell
RNA profiles (although a low broad peak was observed
at the level of 18 S RNA). Analysis of the small RNA
profiles of EV samples revealed enrichment of sequences
of the size expected for miRNAs, with a peak at approxi-
mately 20 nt.
To compare the global miRNA profile of non-
transfected and pSM30-miR-146a transfected cells and
their EVs, small RNA libraries were prepared and
sequenced on an Illumina Genome Analyzer. Raw reads
were subjected to adaptor removal and aligned to miR-
Base (Release 17, http://www.mirbase.org/) [39]. BothFigure 3 MiRNA expression in cells and EVs. Scatter plots of the miRNA
146a transfected cells. A) There was extremely high correlation between m
(R2 = 0.9). B) Strong correlation was also observed between EVs from non-t
transfected and non-transfected cells and D) between EVs from transfected
146a transfected cells and EVs expression levels were renormalized to RPMraw and processed data has been deposited in Gene Ex-
pression Omnibus (GEO: http://www.ncbi.nlm.nih.gov/
geo/), with accession number GSE38916. The total num-
bers of reads >15 bp matching each miRNA were calcu-
lated. These values were then normalized to number of
reads per million mapped (RPMM) in each library, to en-
able direct comparison of expression levels. As a measure
of the relative levels of expression of individual miRNAs
in cells and EVs, the log (base two) of the ratio of the
read number in EVs over that in cells was calculated
(log2 (EV/cell)). The miRNA expression data for cells
and EVs is presented in Additional file 1: Table S1.
The enrichment of miR-146a in cells and EVs follow-
ing transfection with pSM30-miR-146a was striking:
Mir-146a was enriched from 10 RPMM (0.1% of all
reads) to 317,863 RPMM (32%) in cells and from 1,321
RPMM (1.3%) to 440,496 RPMM (44%) in EVs. Sequen-
cing revealed that overexpressed miR-146a was correctly
processed, with the most prevalent isomiR being the
same in all cell and EV libraries (Figure 2A) and repre-
sented by approximately half of the reads. RT-qPCR
from independent pSM30-miR-146a transfections con-
firmed consistently high overexpression of miR-146a in
both cells and EVs (Figure 2B).
To evaluate how the overexpression of miR-146a
affected the proportions of other, endogenous miRNAs,
we excluded reads for miR-146a from transfected cellsexpression levels in cells and EVs of non-transfected and pSM30-miR-
iRNA expression values in non-transfected and transfected cells
ransfected and transfected cells (R2 = 0.8). C) Correlation between
and non-transfected cells was much lower (R2 = 0.6). For pSM30-miR-
M following exclusion of miR-146a reads.
Figure 4 Relative expression between cells and microvesicles. A) The ratios of the expression levels of individual miRNAs between cells and
EVs remained reasonably constant following overexpression of exogenous miR146a expression, as illustrated by the strong correlation between
the values. B) When expression levels in both cells and EVs were normalized to RPMM, more miRNAs were preferentially released in EVs than
retained in cells: The histograms for both non-transfected (blue) and miR-146a overexpressing samples (red) are shifted to the right relative to a
normal distribution (grey line).
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other miRNAs to reads per million mapped (RPMM).
This enabled direct comparison between read numbersTable 1 miRNAs most preferentially released into EVs
miRNA Non-transfected cells & EVs
RPMM cells RPMM EV Log 2 (EV/C
mir-451 0.4 3945.0 13.3
mir-150 0.4 2475.0 12.6
mir-146a* 10.4 1321.2 7.0
mir-320c 24.3 2347.5 6.6
mir-143 39.9 3232.5 6.3
mir-720 65.4 3157.5 5.6
mir-125a-5p 214.7 9360.0 5.4
mir-486 105.7 3900.0 5.2
mir-149 89.0 3142.5 5.1
mir-2110 43.5 1380.0 5.0
mir-320a 762.1 23190.0 4.9
mir-197 472.4 8347.5 4.1
mir-339 91.4 1515.0 4.1
mir-99b 2065.2 27420.0 3.7
mir-4286 108.5 1245.0 3.5
mir-92b 515.1 5542.5 3.4
mir-222 774.1 7882.5 3.3
mir-423-5p 5737.2 55762.5 3.3
mir-877 467.2 4425.0 3.2
mir-191 9501.8 88717.5 3.2
mir-1292 140.0 1222.5 3.1
mir-1246 782.8 6570.0 3.1
Those miRNAs represented by at least 1000 reads in either cells or EV are listed. * F
removal of the reads from over-expressed miR-146a, to facilitate comparison with n
to this normalisation).in transfected and non-transfected cells and EVs. This
re-normalisation revealed extremely high correlation be-
tween miRNA expression values in non-transfected andmiR-146a - Transfected cells & EVs























or the transfected cells and EVs the RPMM values were calculated after
on-transfected samples (the RPMM values shown for miR-146a are those prior
Table 2 miRNAs most preferentially retained within cells
miRNA Non-transfected cells & EVs miR-146a - Transfected cells & EVs
RPMM cells RPMM EV Log 2 (EV/Cells) RPMM cells RPMM EV Log 2 (EV/Cells)
mir-218 1342.24 135.00 −3.31 1460.00 132.60 −3.46
mir-15a 2411.56 435.00 −2.47 2120.00 371.28 −2.51
mir-140 1181.04 277.50 −2.09 1130.00 185.64 −2.61
mir-148b 18756.99 5047.50 −1.89 17300.00 5383.56 −1.68
mir-378 397404.00 109560.00 −1.86 192000.00 117695.76 −0.71
mir-16 7225.49 2100.00 −1.78 7190.00 2625.48 −1.45
mir-20a 45087.00 14460.00 −1.64 52700.00 14957.28 −1.82
mir-424 1230.92 397.50 −1.63 878.00 477.36 −0.88
mir-18a 4535.03 1477.50 −1.62 4520.00 1405.56 −1.69
let-7f 16253.27 5520.00 −1.56 31964.69 11055.00 −1.53
let-7 g 4999.47 1950.00 −1.36 5580.00 4826.64 −0.21
mir-130b 2194.90 877.50 −1.32 2180.00 769.08 −1.50
mir-15b 2820.93 1147.50 −1.30 2780.00 1087.32 −1.35
mir-598 1066.13 435.00 −1.29 1400.00 397.80 −1.82
mir-26b 1594.80 660.00 −1.27 1440.00 689.52 −1.06
mir-340 4503.91 2137.50 −1.08 1870.00 2280.72 0.29
Those miRNAs represented by at least 1000 reads in either cells or EV are listed. * For the transfected cells and EVs the RPMM values were calculated after
removal of the reads from over-expressed miR-146a, to facilitate comparison with non-transfected samples.
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correlation was also observed between EVs from non-
transfected and transfected cells (R2 = 0.8) (Figure 3B).
However, correlation between both transfected and non-
transfected cells and their respective EVs was much
lower (R2 = 0.6) (Figure 3C,D). From all miRNAs that
had been detected in both non-transfected cells and
EVs, only 19.5% had log2 (EV/cell) between −1 and +1,
therefore being represented by similar number of reads
in cells and EVs.
The miRNAs preferentially retained within the cell or
released in EVs are highly consistent even after over-
expression; a scatter plot of log2 ratios of miRNAs
represented by more than 1000 reads either in cells or EVs
revealed relatively high correlation (R2=0.748)(Figure 4A).
The most retained and most released miRNAs which are
represented by more than 1000 reads either in cells or in
EVs are listed in Tables 1 and 2 respectively. MiR-218 was
found to be the most retained and miR-451 the most
exported miRNA. If miRNAs are incorporated passively
into EVs as a random sample of the cellular population
one would expect the ratios of EV:cell expression values to
be approximately 1:1 when both values are normalized to
million reads mapped (i.e. a distribution of log2 (EV/cell)
centred on zero). However, we observed a skewed distribu-
tion (Figure 4B), with more miRNAs represented by higher
RPMM values in EVs than cells (i.e. with a positive log2
(EV/cell) ratio). The values of the positive ratios represent-
ing the most released miRNAs, were more extreme thanthe most negative values. However, several very highly
expressed miRNAs had negative values (i.e. preferentially
retained within the cell).
To confirm sequencing data, we performed RT-qPCR
on RNA samples isolated from biological replicates of
non-transfected and pSM30miR-146a transfected cells
and their EVs. MiR-26a was chosen for normalization of
the RT-qPCR data because this miRNA had relatively
high expression (~2000 RPMM) and the numbers of
reads in cells and EVs were similar (EV:Cell ratio ~1).
The miRNA EV:cell ratios obtained by PCR correlated
with sequencing data and confirmed retained and
exported miRNAs (Figure 5A).
The most highly exported miRNA in EVs in our data,
miR-451, was also reported previously to be highly
exported from breast cancer cells lines and mesenchy-
mal stem cells [25,33]. This was intriguing, and it
prompted us to speculate that the same miRNAs may be
preferentially exported or retained in various cell types.
We therefore tested two other cell types, namely a
human microvascular endothelial cell line, (HMEC-1)
and primary outgrowth endothelial progenitor cells
(OECs) with the same panel of primers used to confirm
sequencing data in HEK293T cells. For the 12 miRNAs
expressed in both endothelial cells and EVs the propor-
tions retained or released followed a similar pattern to
that observed in HEK293T cells (Figure 5B). Two miR-
NAs, miR-1246 and miR-9 were not detected and miR-7
was not detected in endothelial EVs.
Figure 5 Comparison of EV:cells ratios obtained by RT-qPCR and deep sequencing. A) Confirmation of EV:cells ratios by RT-qPCR for miRNA
in biological replicates of non-transfected and pSM30-146a transfected HEK293T cells. B) Comparison of EV:cells ratios from HEK293T cells (deep
sequencing) with HMEC-1 and OEC cells (RT-qPCR). RT-qPCR data were normalized to miR-26a.
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cells types, we retrieved publicly available data (microarray
and RT-qPCR arrays) on miRNA expression in various
cell types and their EVs (microvesicles, exosomes). The
ratios (or delta Ct for RT-qPCR data) between the expres-
sion levels in EVs and cells were calculated and the miR-
NAs ranked accordingly. Comparison of the ranks of the
miRNAs present in our data with their ranks in the other
datasets revealed correlations between the different cell
types. This was visualized by assigning a color for each
miRNA according to its rank in a particular data set:
Figure 6A shows the ranks of the top and bottom 100
miRNAs sorted according to the data from HEK293T
non-transfected cells (all miRNAs are listed in Additional
file 2: Table S2). MiR-451, the most highly enriched
miRNA in HEK293T EVs, was among the top 6 exported
miRNAs in 6 out of 8 of the other datasets.MiR-451 is the only reported miRNA that is not pro-
cessed by Dicer, but instead uses an Ago2-mediated
pathway for its maturation [40-42]. It is tempting to
speculate that this unique processing pathway might be
connected with the high extracellular export of miR-451.
In this case one might expect the most exported miR-
NAs to also be the most affected by loss of Ago2 activity.
We therefore ranked miRNAs according to the reduc-
tion in their expression in bone marrow of Ago2 ko
mice compared to the wild type [43]. Remarkably, in
addition to miR-451, several other miRNAs among the
top 6 affected by the Ago2 deletion (miR150, miR-486,
and miR-144) were also found to be highly exported in
several data sets (see column (K) in Figure 6).
As an initial step towards understanding the function
of the preferentially exported miRNAs we attempted to
determine the genes which are being targeted by these
Figure 6 Overlap between miRNAs exported by different cell types. All miRNAs identified in HEK293T cells were coloured according to their
EV:cells ratio with most preferentially exported red and most retained within the cell green. The 100 miRNAs with the smallest and largest log2
(EV/cell) values are shown on the left. Publicly available data sets for various cell types were analysed in a similar fashion and compared with our
data. The pattern of exported and retained miRNAs shows similarities between the different data sets. The most exported miRNAs cluster
predominantly in the upper part of the graph which is enlarged in the central panel to show the identities of the consistently exported miRNAs.
The right-hand column (column K) illustrates the miRNAs ranked according to reduction in Ago2 knockout tissue relative to wildtype reported by
Yang et al. [43]. Arrows indicate miRNAs with high ranks in both Ago2 and other data sets. Blank white spaces indicate that a miRNA was either
not detected or not assayed.
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Figure 7 Targets of selectively exported miRNAs are involved in endocytosis. The endocytosis pathway (Kegg: hsa:04144) is depicted with
the target genes of the 10 most exported miRNAs highlighted. Those genes predicted by Diana microT-CDS are highlighted in yellow, those by
Starbase (supported by CLIP-Seq data) in pink and those by both approaches in orange.
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with certainty, but the algorithms available are improv-
ing. We employed microT-CDS, which has recently
been shown to perform well in terms of sensitivity and
specificity compared to other available algorithms [44].
The 2760 genes predicted to be targeted by one or
more of the ten most selectively exported miRNAs are
listed in Additional file 3: Table S3. Functional analysis
of these genes revealed that the most enriched pathway
was endocytosis (Kegg hsa04144) (Benjamini-corrected
p-value = 0.05) which contained 43 predicted target
genes (Figure 7). All the enriched pathways and gene
ontologies are listed in Additional file 4: Table S4 as
well as clusters of functionally related terms, which in-
clude transcriptional regulation, intracellular transport
and organelles. Recently developed techniques based
upon crosslinking of RISC proteins with their target
mRNAs have facilitated experimental determination
of miRNA:target interactions [45,46]. Therefore, tocomplement the in silico target prediction, the genes with
target sites for the same 10 most exported miRNAs pre-
dicted by any algorithm that are supported experimentally
by CLIP-Seq reads available in Starbase [47] were down-
loaded (Additional file 3: Table S3). These genes were
also significantly enriched in the endocytosis pathway
(Benjamini-corrected p-value = 0.0009) and because
only three of the predicted target genes in this pathway
are common (Figure 7) the in silico and experimental
predictions provide largely independent associations
with endocytosis. From the total of 43 microT-CDS and
39 Starbase predicted target genes 7 were common.
Discussion
MiRNAs are involved in regulation of a wide array of
biological processes, from development to immunity.
Extracellular and circulating miRNAs have been found
both in the non-vesicular fraction and encapsulated in
EVs. They have been shown to associate with lipids
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of EV miRNAs in cell-to-cell communication has now
been widely accepted [3] and HDL-mediated miRNA
transfer has been shown to regulate recipient cell gene
expression [19], there is still no direct evidence that
miRNAs associated with proteins act in a paracrine fash-
ion [16-18].
Realisation of the potential importance of miRNAs in
cell-to-cell communication has triggered research into
the mechanisms of miRNA release and their effects
upon recipient cells [4]. Evidence is accumulating that
miRNA export into EVs is selective, but it is not known
how this export is regulated. Several studies have com-
pared the miRNA content of cells and EVs using micro-
arrays or RT-qPCR. Deep sequencing is an alternative
approach for measuring miRNA expression which has
the advantage of providing a digital measure that does
not require an internal standard for normalisation. This
is particularly important when comparing miRNA levels
between cells and EVs, where no common internal stan-
dards have been identified. Although several previous
studies have applied deep sequencing in similar scenar-
ios, they involved fewer reads and the expression of only
selected miRNAs was reported [48,49]. Here we report a
global comparison of the miRNA pools in HEK293T
cells and their EVs. Our analysis confirmed previous
observations that some miRNAs are preferentially
exported and found to be enriched in EVs.
Enrichment of a miRNA in EVs after its overexpression
in cells has been measured previously by RT-qPCR. How-
ever, it is important to reveal how such overexpression
compares with and affects expression and export of en-
dogenous miRNAs. We found overexpressed miR-146a
to contribute almost a third of all reads in cells and even
more in EVs, representing almost half of their cargo. It is
very important for the miRNA therapeutic field to under-
stand the consequence of miRNA overexpression. Our
data suggest that if a miRNA is overexpressed in a spe-
cific cell type the possibility that a significant amount of
this miRNA will be exported and potentially affect other
cells should be considered. Although we cannot assess
the effect of miR-146a overexpression upon the absolute
expression of other miRNAs, this effect is likely to be
similar in both cells and EVs. However, our data demon-
strates that the relative expression levels of endogenous
miRNAs (and their EV:cell miRNA ratios) remain very
stable and are largely unaffected by the miRNA overex-
pression. The fact that selective miRNA export is tightly
regulated suggests that it plays an important role in cell
physiology. This will be an important consideration not
only for further studies into the mechanism of miRNA
export but also for the development of methods for en-
richment of EVs with miRNA for therapies. It is possible
that the overexpressed miRNA and endogenous miRNAsuse different export routes and therefore do not affect
each other. Since our EV preparation does not distin-
guish between exosomes and shedding vesicles we cannot
exclude that one of these is preferentially used to carry
overexpressed miRNA. Fractionation of EVs will be ne-
cessary to further examine this possibility. Nevertheless,
there may be an overlap between the two pathways, as a
recent study has suggested that shedding vesicles and
exosomes require the same GTPase (RAB-11) and
ESCRT proteins for their biogenesis and therefore may
be regulated by the same mechanisms, regardless of their
distinct cellular localization [31].
Comparison of our data with publicly available expres-
sion sets from other cell types revealed that some miR-
NAs tend to be universally exported. It is possible that
this reflects release of the same type of vesicles (eg exo-
some) by all the cell types analysed. The commonly
exported miRNAs possibly fulfill a common function in
intercellular communication. MiR-451 was found to be
the miRNA with the highest ratio between expression
levels in EVs and cells. In relation to its maturation miR-
451 is a non-canonical miRNA, processed by the Ago2
protein, in contrast to other miRNAs that commonly re-
quire Dicer for this process [40,41,43]. Ago2 has been
shown previously to be associated with both EV and
non-vesicular miRNAs [17,18,49]. Comparison of
miRNA expression between cells and their EV counter-
parts from other published data sets reveals miR-451 to
be one of the most highly exported miRNAs in multiple
cell types. Deletion of Ago2 in bone marrow leads to
reduced expression of several other miRNAs in addition
to miR-451 [43], notably some of the miRNAs that are
most preferentially exported from various different cell
types. These data suggest that there may be a connection
between Ago2 processing and the selection of miRNAs
for export. Recent studies have demonstrated the phys-
ical colocalisation of RISC and MVBs and their func-
tional interactions in regulating miRNA loading and
RNA silencing [49,50]. Being a key component of RISC,
Ago2 may potentially be involved in directing miRNA
towards exosomal secretion. However it has not been
investigated whether Ago2 mediated miR-451 processing
also occurs within RISC and in colocalisation with MVB
membrane, or in another subcellular compartment. Fu-
ture studies are required to characterize miRNA export
into specific EV populations and must also address the
challenge of dissecting the function of Ago2 in miRNA
processing from its potential role in miRNA export.
Conclusions
Specific endogenous miRNAs, most notably miR-451 are
selectively released from HEK293T cells in EVs by a
process that may involve Ago2. Conservation amongst
the miRNAs exported by different cells suggests that this
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functions. Enrichment in genes involved in endocytosis
amongst the targets of the most selectively exported
miRNAs suggests that these functions may include inter-
cellular vesicular transport itself. The demonstration that
EV miRNA content can be manipulated by cellular over-
expression of a specific miRNA bodes well for future
therapeutic use of this system to deliver miRNAs/siR-
NAs to target cells.
Methods
Cell culture
HEK293T cells from the American Type Culture Collec-
tion (ATCC) were cultured in DMEM (Life technologies,
Paisley, UK) supplemented with 10% fetal calf serum
(FCS) and 100 μg/ml Primocin™ (InvivoGen). Human
microvascular endothelial cells (HMEC-1) [51] were cul-
tured in MCDB 131 medium (Life technologies) contain-
ing 10% FCS, L-glutamine (2 mM), epidermal growth
factor (10 ng/ml, Life technologies), hydrocortisone
(1 μg/ml, Life technologies), and 100 μg/ml Primocin.
As described previously [52], OECs were obtained from
the mononuclear cell fraction of umbilical cord blood,
obtained under full ethical approval from The Office
for Research Ethics Committees Northern Ireland
(ORECNI). Cells were resuspended in EGM-2 medium
(Lonza) supplemented with 10% FCS and seeded on 24
well culture plates pre-coated with rat tail collagen type
1 (BD Biosciences) at a density of 1×107/ml All cells
were cultured under standard conditions at 5% CO2,
37°C, and 95% humidity.
MiRNA cloning
The mature miRNA sequences for miR-146a, were
inserted into pSM30 vector according to the published
protocol [53]. Briefly, the oligos containing the miR-146a
mature sequence and the miR-30 loop sequence were
designed as follows: top strand miR-146a oligo: 5'- AGCG
GACCCATGGAATTCAGTTCTCATAGTGAAGCCACA
GATGTATGAGAACTGAATTCCATGGGTT-3' and the
bottom strand miR-146a oligo: 5'-GGCAAACCCATGG
AATTCAGTTCTCATACATCTGTGGCTTCACTATGA
GAACTGAATTCCATGGGTC-3'). Oligos were synthesized
and HPLC purified by Eurogentec (Seraing, Belgium).
Five μl of each oligo (100 μM stock solution) were mixed
with 8 μl water and 2 μl of 10 x restriction buffer 3 (New
England Biolabs), heated at 95°C for 4 minutes and left at
room temperature for 15 minutes to anneal. Annealed
oligos were diluted 2500 x to get 10 nM for ligation.
Annealed oligos were ligated into pSM30 vector using
Rapid Ligation Kit (Roche) with 15:1 insert:vector ratio.
pSM30 empty vector was digested with BSMBI restric-
tion enzyme and linearized plasmid was gel purified.
DH5α competent cells were transformed with theligation reaction and positive colonies were selected on
agar plates supplemented with kanamycin.
Transfection
HEK293T cells were seeded at 3×104 cells/ml into T75
flasks and transfected after 24 hours with Turbofect
in vitro transfection reagent (Fermentas, York, UK)
according to the manufacturer’s instructions. After 16
hours media were replaced with media containing 10%
serum depleted of EVs by centrifugation for 2 hours at
100000 g. EVs were collected from the conditioned
media after 48 h hours.
Isolation and characterisation of EVs
EVs were isolated as described previously [25,54]. Cell
debris was removed by centrifugation at 2000 g for 30
minutes and vesicles were isolated by ultracentrifugation
at 100000 g for 1 hour.
For Electron microscopy HEK293T EVs pellets were
fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate
buffer at 4°C overnight. After post-fixation in 1% os-
mium tetroxide, pellets were dehydrated with increasing
alcohol concentrations and embedded in Spurr resin.
Ultrathin sections were prepared using an ultramicro-
tome, placed on copper grids (Agar Scientific Ltd, UK),
stained with uranyl acetate and lead citrate, and exam-
ined using a JEOL 100 CX transmission electron
microscope.
RNA extraction
RNA was extracted using a miRNeasy kit (Qiagen,
Crawley, UK) or High pure miRNA isolation kit (Roche,
Burgess Hill, UK) according to the manufacturers’ proto-
cols. RNA purity and quantity was determined using a
Nanodrop spectrophotometer (Thermo Scientific) or
Qubit fluorimeter (Life Technologies). RNA integrity
was assessed using RNA 2000 and small RNA chips on a
Bioanalyzer (Agilent).
Deep sequencing
Small RNA libraries were prepared using a sample prep
kit v1.5 kit (Illumina) following the manufacturer’s
protocol. Cluster generation and sequencing on a Gen-
ome Analyzer II was performed at the Trinity Genome
Sequencing Laboratory, Dublin (http://www.medicine.
tcd.ie/sequencing). Sequencing data were analyzed
using Genomics workbench software (CLCbio, Aarhus,
Denmark). After removal of adapter sequences reads
>15 bp were aligned to miRBase (Release 17) for anno-
tation, allowing no more than 2 mismatches. Reads were
normalized to reads per million mapped (RPMM) to en-
able comparison between different libraries. If a miRNA
was found in both EV data sets but was detected in only
one data set from cells (due to its low expression value)
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purpose of calculating an EV:cells ratio.
Target genes were predicted for miRNAs of interest
using the microT-CDS algorithm available at www.
microrna.gr/microT-CDS with a strict miTG Score
Threshold of 0.8 [44]. Lists were integrated using Micro-
soft Access and pathway analysis of the KEGG database
[55] performed using the The Database for Annotation,
Visualization and Integrated Discovery (DAVID) v6.7
[56] available at http://david.abcc.ncifcrf.gov/. Predicted
target sites supported by CLIP-Seq reads were down-
loaded from Starbase (http://starbase.sysu.edu.cn/) [47].
RT-qPCR
Specific miRNAs were amplified using a modified version
of the method described by Shi and Chiang [57]. One
microgram of RNA was polyadenylated using poly(A)
polymerase (PAP; Ambion, Foster City, CA) at 37°C for 1
hour in a 25 μl reaction mixture. RNA was then reverse
transcribed with 200 U of SuperScript III reverse tran-
scriptase (Life technologies, Paisley, UK) and 0.5 μg poly
(T) adapter. Primers for specific miRNAs were designed
from miRNA sequences obtained from miRBase and our
sequencing data and synthesized by Eurogentec (Seraing,
Liège, Belgium) (Additional file 5: Table S5). The reverse
primer was the 3' adapter primer (3' RACE outer primer
in the FirstChoice RLM-RACE kit; Ambion).
RT-qPCR was performed using Maxima SYBR Green
qPCR mastermix (Fermentas) in 10 μl reactions contain-
ing 2 μl of 1:15 cDNA dilution. Reactions were per-
formed on a LightCycler 480 (Roche), with the initial
preincubation at 50°C for 2 min and activation at 95°C
for 10 min, followed by 40 cycles at 95°C for 15 s, and
60°C for 60 s, with fluorescence acquired after 15 s of the
60°C step. Primer efficiencies were determined using ser-
ial dilutions of pooled cDNA and the reactions were
optimized to achieve efficiencies of ~2 for all primers
used. The RNA from three independent experiments was
analyzed and all PCR reactions were performed in tripli-
cates. Gene expression data were normalized to miR-26a.
The relative expression was determined as 2−ΔCt, where
ΔCt =Ct(miRNA)-Ct(miR-26a).
Analysis of publicly available miRNA expression data
Publicly available data were included in analysis if they
had expression data for EVs (exosomes, microvesicles)
and corresponding cells. Microarray data were down-
loaded from GEO database [27,28,33] or retrieved from
supplementary data [58,59]. Difference between expres-
sion in cells and EVs was determined as the ratio of ex-
pression EV:cells for microarrays or as delta Ct for RT-
qPCR arrays and miRNAs were ranked accordingly.
Using Microsoft Access miRNAs that are present in our
data were pulled out from all the other data sets withtheir own ranks kept. Colours were assigned to miRNAs
according to their ranks using Microsoft Excel (condi-
tional formatting).
Additional files
Additional file 1: Table S1. RPMM cells and EVs.
Additional file 2: Table S2. Full list of ranked miRNAs shown in
Figure 6.
Additional file 3: Table S3. Target predictions.
Additional file 4: Table S4. Functional annotation.
Additional file 5: Table S5. Primer sequences.
Abbreviations
CLIP-Seq: Crosslinking immunoprecipitation sequencing; EVs: Extracellular
vesicles; HMEC-1: Human microvascular endothelial cell line;
MVB: Multivesicular bodies; OECs: Outgrowth endothelial progenitor cells;
RISC: RNA-Induced Silencing Complex; RPMM: Reads per million mapped.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JG-F contributed to the design of the study, carried out library preparation,
sample preparation and RT-qPCR, participated in the analysis of sequence
data and drafted the manuscript. AOC constructed the miR-146a expression
vector. BC performed RT-qPCR expression analyses. CLO isolated OECs. RJM
isolated OECs and assisted with manuscript preparation. DAS conceived,
designed and co-ordinated the study, analysed the sequence data and
drafted the manuscript. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by grant number BB/H005498/1from the
Biotechnology and Biological Sciences Research Council (BBSRC). The authors
thank Gerry Mahon and Liza Colhoun for assistance with electron
microscopy and Dr. G. Du (University of Texas Health Science Center at
Houston, TX, USA) for kindly providing pSM30. The Trinity Genome
Sequencing Laboratory is a core facility funded by Science Foundation
Ireland and supported by the Trinity Centre for High Performance
Computing.
Received: 30 April 2012 Accepted: 16 July 2012
Published: 1 August 2012
References
1. Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C: Exosome/
microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer
Res 2011, 1(1):98–110.
2. Cocucci E, Racchetti G, Meldolesi J: Shedding microvesicles: artefacts no
more. Trends Cell Biol 2009, 19(2):43–51.
3. Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B, Laszlo V, Pallinger E,
Pap E, Kittel A, Nagy G, Falus A, Buzas EI: Membrane vesicles, current state-
of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011,
68(16):2667–2688.
4. Chen X, Liang H, Zhang J, Zen K, Zhang CY: Secreted microRNAs: a new
form of intercellular communication. Trends Cell Biol 2012, 22(3):125–132.
5. Anderson HC, Mulhall D, Garimella R: Role of extracellular membrane
vesicles in the pathogenesis of various diseases, including cancer, renal
diseases, atherosclerosis, and arthritis. Lab Invest 2010, 90(11):1549–1557.
6. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X, Sun Q,
Wang K, Ba Y, Wang Q, Wang D, Yang J, Liu P, Xu T, Yan Q, Zhang J, Zen K,
Zhang CY: Secreted monocytic miR-150 enhances targeted endothelial
cell migration. Mol Cell 2010, 39(1):133–144.
7. Quesenberry PJ, Dooner MS, Aliotta JM: Stem cell plasticity revisited: the
continuum marrow model and phenotypic changes mediated by
microvesicles. Exp Hematol 2010, 38(7):581–592.
Guduric-Fuchs et al. BMC Genomics 2012, 13:357 Page 13 of 14
http://www.biomedcentral.com/1471-2164/13/3578. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C:
Microvesicles: mediators of extracellular communication during cancer
progression. J Cell Sci 2010, 123(Pt 10):1603–1611.
9. Yuan A, Farber EL, Rapoport AL, Tejada D, Deniskin R, Akhmedov NB, Farber
DB: Transfer of microRNAs by embryonic stem cell microvesicles. PLoS
One 2009, 4(3):e4722.
10. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function.
Cell 2004, 116(2):281–297.
11. Wu L, Belasco JG: Let me count the ways: mechanisms of gene
regulation by miRNAs and siRNAs. Mol Cell 2008, 29(1):1–7.
12. Hata T, Murakami K, Nakatani H, Yamamoto Y, Matsuda T, Aoki N: Isolation
of bovine milk-derived microvesicles carrying mRNAs and microRNAs.
Biochem Biophys Res Commun 2010, 396(2):528–533.
13. Kosaka N, Iguchi H, Ochiya T: Circulating microRNA in body fluid: a new
potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010,
101(10):2087–2092.
14. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH: Exosomal
microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009,
10(1):42–46.
15. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry
WT Jr, Carter BS, Krichevsky AM, Breakefield XO: Glioblastoma microvesicles
transport RNA and proteins that promote tumour growth and provide
diagnostic biomarkers. Nat Cell Biol 2008, 10(12):1470–1476.
16. Wang K, Zhang S, Weber J, Baxter D, Galas DJ: Export of microRNAs and
microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010,
38(20):7248–7259.
17. Turchinovich A, Weiz L, Langheinz A, Burwinkel B: Characterization of
extracellular circulating microRNA. Nucleic Acids Res 2011,
39(16):7223–7233.
18. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS,
Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M:
Argonaute2 complexes carry a population of circulating microRNAs
independent of vesicles in human plasma. Proc Natl Acad Sci U S A 2011,
108(12):5003–5008.
19. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT:
MicroRNAs are transported in plasma and delivered to recipient cells by
high-density lipoproteins. Nat Cell Biol 2011, 13(4):423–433.
20. Taylor DD, Gercel-Taylor C: MicroRNA signatures of tumor-derived
exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol
2008, 110(1):13–21.
21. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li
Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang
J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang
CY: Characterization of microRNAs in serum: a novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res 2008, 18(10):997–1006.
22. Contu R, Latronico MV, Condorelli G: Circulating microRNAs as potential
biomarkers of coronary artery disease: a promise to be fulfilled? Circ Res
2010, 107(5):573–574.
23. Gupta SK, Bang C, Thum T: Circulating microRNAs as biomarkers and
potential paracrine mediators of cardiovascular disease. Circ Cardiovasc
Genet 2010, 3(5):484–488.
24. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T: Secretory
mechanisms and intercellular transfer of microRNAs in living cells. J Biol
Chem 2010, 285(23):17442–17452.
25. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, Tetta C,
Camussi G: Microvesicles derived from adult human bone marrow and
tissue specific mesenchymal stem cells shuttle selected pattern of
miRNAs. PLoS One 2010, 5(7):e11803.
26. Iguchi H, Kosaka N, Ochiya T: Secretory microRNAs as a versatile
communication tool. Commun Integr Biol 2010, 3(5):478–481.
27. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, Gonzalez S, Sanchez-
Cabo F, Gonzalez MA, Bernad A, Sanchez-Madrid F: Unidirectional transfer
of microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commun 2011, 2:282.
28. Montecalvo A, Larregina AT, Shufesky WJ, Beer Stolz D, Sullivan ML, Karlsson
JM, Baty CJ, Gibson GA, Erdos G, Wang Z, Milosevic J, Tkacheva OA, Divito
SJ, Jordan R, Lyons-Weiler J, Watkins SC, Morelli AE: Mechanism of transfer
of functional microRNAs between mouse dendritic cells via exosomes.
Blood 2012, 119(3):756–766.
29. Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, Zeiher AM,
Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA,Dimmeler S: Atheroprotective communication between endothelial cells
and smooth muscle cells through miRNAs. Nat Cell Biol 2012,
14(3):249–256.
30. Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, Sordi A,
Biancone L, Tetta C, Camussi G: Microvesicles derived from endothelial
progenitor cells protect the kidney from ischemia-reperfusion injury by
microRNA-dependent reprogramming of resident renal cells. Kidney Int
2012, 82(4):412–27.
31. Wehman AM, Poggioli C, Schweinsberg P, Grant BD, Nance J: The P4-
ATPase TAT-5 inhibits the budding of extracellular vesicles in C. elegans
embryos. Curr Biol 2011, 21(23):1951–1959.
32. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK: Mesenchymal stem
cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res
2010, 38(1):215–224.
33. Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D,
Hastings ML, Duelli DM: Selective release of microRNA species from
normal and malignant mammary epithelial cells. PLoS One 2010,
5(10):e13515.
34. Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y,
Muramatsu K, Fukuda Y, Ogura S, Yamaguchi K, Mochizuki T: Let-7
microRNA family is selectively secreted into the extracellular
environment via exosomes in a metastatic gastric cancer cell line. PLoS
One 2010, 5(10):e13247.
35. Lai RC, Chen TS, Lim SK: Mesenchymal stem cell exosome: a novel stem cell-
based therapy for cardiovascular disease. Regen Med 2011, 6(4):481–492.
36. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ: Delivery of
siRNA to the mouse brain by systemic injection of targeted exosomes.
Nat Biotechnol 2011, 29(4):341–345.
37. Akao Y, Iio A, Itoh T, Noguchi S, Itoh Y, Ohtsuki Y, Naoe T: Microvesicle-
mediated RNA molecule delivery system using monocytes/macrophages.
Mol Ther 2011, 19(2):395–399.
38. van Dommelen SM, Vader P, Lakhal S, Kooijmans SA, van Solinge WW,
Wood MJ, Schiffelers RM: Microvesicles and exosomes: Opportunities for
cell-derived membrane vesicles in drug delivery. J Control Release 2011,
161(2):635–44.
39. Kozomara A, Griffiths-Jones S: miRBase: integrating microRNA annotation
and deep-sequencing data. Nucleic Acids Res 2011, 39(Database issue):
D152–D157.
40. Cheloufi S, Dos Santos CO, Chong MM, Hannon GJ: A dicer-independent
miRNA biogenesis pathway that requires Ago catalysis. Nature 2010,
465(7298):584–589.
41. Cifuentes D, Xue H, Taylor DW, Patnode H, Mishima Y, Cheloufi S, Ma E,
Mane S, Hannon GJ, Lawson ND, Wolfe SA, Giraldez AJ: A novel miRNA
processing pathway independent of Dicer requires Argonaute2 catalytic
activity. Science 2010, 328(5986):1694–1698.
42. Yang JS, Lai EC: Dicer-independent, Ago2-mediated microRNA biogenesis
in vertebrates. Cell Cycle 2010, 9(22):4455–4460.
43. Yang JS, Maurin T, Robine N, Rasmussen KD, Jeffrey KL, Chandwani R,
Papapetrou EP, Sadelain M, O'Carroll D, Lai EC: Conserved vertebrate mir-
451 provides a platform for Dicer-independent, Ago2-mediated
microRNA biogenesis. Proc Natl Acad Sci U S A 2010, 107(34):15163–15168.
44. Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG: Functional
microRNA targets in protein coding sequences. Bioinformatics 2012,
28(6):771–776.
45. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P,
Rothballer A, Ascano M Jr, Jungkamp AC, Munschauer M, Ulrich A, Wardle
GS, Dewell S, Zavolan M, Tuschl T: Transcriptome-wide identification of
RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010,
14(1):129–141.
46. Chi SW, Zang JB, Mele A, Darnell RB: Argonaute HITS-CLIP decodes
microRNA-mRNA interaction maps. Nature 2009, 460(7254):479–486.
47. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH: starBase: a database for
exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq
and Degradome-Seq data. Nucleic Acids Res 2011, 39(Database issue):
D202–D209.
48. Koh W, Sheng CT, Tan B, Lee QY, Kuznetsov V, Kiang LS, Tanavde V:
Analysis of deep sequencing microRNA expression profile from
human embryonic stem cells derived mesenchymal stem cells
reveals possible role of let-7 microRNA family in downstream
targeting of hepatic nuclear factor 4 alpha. BMC Genomics 2010,
11(Suppl 1):S6.
Guduric-Fuchs et al. BMC Genomics 2012, 13:357 Page 14 of 14
http://www.biomedcentral.com/1471-2164/13/35749. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O: Multivesicular bodies
associate with components of miRNA effector complexes and modulate
miRNA activity. Nat Cell Biol 2009, 11(9):1143–1149.
50. Lee YS, Pressman S, Andress AP, Kim K, White JL, Cassidy JJ, Li X, Lubell K,
do Lim H, Cho IS, Nakahara K, Preall JB, Bellare P, Sontheimer EJ, Carthew
RW: Silencing by small RNAs is linked to endosomal trafficking. Nat Cell
Biol 2009, 11(9):1150–1156.
51. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley
TJ: HMEC-1: establishment of an immortalized human microvascular
endothelial cell line. J Invest Dermatol 1992, 99(6):683–690.
52. Medina RJ, O'Neill CL, Humphreys MW, Gardiner TA, Stitt AW:
Outgrowth endothelial cells: characterization and their potential
for reversing ischemic retinopathy. Invest Ophthalmol Vis Sci 2010,
51(11):5906–5913.
53. Du G, Yonekubo J, Zeng Y, Osisami M, Frohman MA: Design of expression
vectors for RNA interference based on miRNAs and RNA splicing. FEBS J
2006, 273(23):5421–5427.
54. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L,
Bruno S, Bussolati B, Camussi G: Endothelial progenitor cell derived
microvesicles activate an angiogenic program in endothelial cells by a
horizontal transfer of mRNA. Blood 2007, 110(7):2440–2448.
55. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M: KEGG for
representation and analysis of molecular networks involving diseases
and drugs. Nucleic Acids Res 2010, 38(Database issue):D355–D360.
56. da Huang W, Sherman BT, Lempicki RA: Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources. Nat
Protoc 2009, 4(1):44–57.
57. Shi R, Chiang VL: Facile means for quantifying microRNA expression by
real-time PCR. Biotechniques 2005, 39(4):519–525.
58. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO: Exosome-
mediated transfer of mRNAs and microRNAs is a novel mechanism of
genetic exchange between cells. Nat Cell Biol 2007, 9(6):654–659.
59. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee
ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB: Detection of
microRNA expression in human peripheral blood microvesicles. PLoS One
2008, 3(11):e3694.
doi:10.1186/1471-2164-13-357
Cite this article as: Guduric-Fuchs et al.: Selective extracellular vesicle-
mediated export of an overlapping set of microRNAs from multiple cell
types. BMC Genomics 2012 13:357.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
